Jiangsu Hualan New Pharmaceutical Material Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 267.56 million compared to CNY 397.34 million a year ago. Revenue was CNY 268.23 million compared to CNY 397.98 million a year ago.

Net income was CNY 56.15 million compared to CNY 107.87 million a year ago. Basic earnings per share from continuing operations was CNY 0.42 compared to CNY 1.07 a year ago. Diluted earnings per share from continuing operations was CNY 0.42 compared to CNY 1.07 a year ago.